title: Genetic technologies, health care policy and the patent bargain.
abstract: The idea of granting patents on human genetic material continues to cause controversy. The debate is largely focussed on the moral acceptability of human gene patents, the impact of gene patents on the research environment and the value of patents to stimulate innovation and the commercialization and dissemination of genetic discoveries. As highlighted by a recent controversy in Canada, patents can also have a profound effect on health policy and access to genetic services. Creative and bold patent reform initiatives are necessary to ensure that society will, to the highest degree possible, reap the health care benefits of the genetic revolution.
authors.affiliation: Faculty of Law, University of Alberta, Edmonton, Alberta, Canada. tcaulfld@law.ualberta.ca
authors.forename: T A
authors.initials: TA
authors.lastname: Caulfield
authors.forename: B M
authors.initials: BM
authors.lastname: Knoppers
authors.forename: E R
authors.initials: ER
authors.lastname: Gold
authors.forename: L E
authors.initials: LE
authors.lastname: Sheremeta
authors.forename: P J
authors.initials: PJ
authors.lastname: Bridge
mesh_terms: D002170:Canada; D015894:Genome, Human; D006291:Health Policy; D006801:Humans; D010330:Patents as Topic / Q000941:ethics* / Q000331:legislation & jurisprudence